HPS Pharmacies wish to advise that GlaxoSmithKline Australia are currently experiencing an interruption to the supply of:
This supply interruption is due to manufacturing issues. Normal supplies are expected to resume on 31 October, 2016. This has also created an increased demand for related products such as Fucidin® ointment (sodium fusidate) which is expected to experience limited availability until 1 July, 2016.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or GlaxoSmithKline Australia on (03) 9721 8600.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.